z-logo
open-access-imgOpen Access
α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (KrasG12D, and KrasG12D/tp53R270H) mice
Author(s) -
Raj Kumar Verma,
Wei Yu,
Anju Shrivastava,
Sharmila Shankar,
Rakesh Srivastava
Publication year - 2016
Publication title -
scientific reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 213
ISSN - 2045-2322
DOI - 10.1038/srep32743
Subject(s) - homeobox protein nanog , cancer research , pancreatic cancer , cyclopamine , cancer stem cell , gli1 , sox2 , cd44 , stem cell , carcinogenesis , metastasis , biology , chemistry , hedgehog signaling pathway , microbiology and biotechnology , cancer , transcription factor , cell , signal transduction , embryonic stem cell , induced pluripotent stem cell , biochemistry , genetics , gene
Activation of sonic hedgehog (Shh) in cancer stem cell (CSC) has been demonstrated with aggressiveness of pancreatic cancer. In order to enhance the biological activity of α-mangostin, we formulated mangostin-encapsulated PLGA nanoparticles (Mang-NPs) and examined the molecular mechanisms by which they inhibit human and KC mice (Pdx Cre ;LSL-Kras G12D ) pancreatic CSC characteristics in vitro , and pancreatic carcinogenesis in KPC (Pdx Cre ;LSLKras G12D ;LSL-Trp53 R172H ) mice. Mang-NPs inhibited human and Kras G12D mice pancreatic CSC characteristics in vitro . Mang-NPs also inhibited EMT by up-regulating E-cadherin and inhibiting N-cadherin and transcription factors Slug, and pluripotency maintaining factors Nanog, c-Myc, and Oct4. Furthermore, Mang-NPs inhibited the components of Shh pathway and Gli targets. In vivo , Mang-NPs inhibited the progression of pancreatic intraneoplasia to pancreatic ductal adenocarcinoma and liver metastasis in KPC mice. The inhibitory effects of Mang-NPs on carcinogenesis in KPC mice were associated with downregulation of pluripotency maintaining factors (c-Myc, Nanog and Oct4), stem cell markers (CD24 and CD133), components of Shh pathway (Gli1, Gli2, Patched1/2, and Smoothened), Gli targets (Bcl-2, XIAP and Cyclin D1), and EMT markers and transcription factors (N-cadherin, Slug, Snail and Zeb1), and upregulation of E-cadherin. Overall, our data suggest that Mang-NPs can inhibit pancreatic cancer growth, development and metastasis by targeting Shh pathway.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here